Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
China
· Delayed Price · Currency is CNY 8.69
-0.14 (-1.59%)
Apr 2, 2025, 2:45 PM CST
SHE:300009 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 706.95 | 847.23 | 703.26 | 206.63 | 358.96 | Upgrade
|
| Depreciation & Amortization | 120.96 | 101.11 | 86.57 | 80.95 | 65.99 | Upgrade
|
| Other Amortization | 3.19 | 1.94 | 2.3 | 7.79 | 4.31 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.09 | -0.12 | 1.2 | -1.68 | 0.02 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.15 | 1.49 | 4.47 | 323.44 | 0.03 | Upgrade
|
| Loss (Gain) From Sale of Investments | -26.04 | 15.44 | -24.66 | -3.86 | 15.42 | Upgrade
|
| Provision & Write-off of Bad Debts | 7.19 | 20.12 | 5.37 | 4.62 | 3.84 | Upgrade
|
| Other Operating Activities | 15.86 | 13.3 | 11.02 | 3.7 | -7.73 | Upgrade
|
| Change in Accounts Receivable | -20.45 | -214.07 | -37.65 | -114.19 | -18.56 | Upgrade
|
| Change in Inventory | -69.93 | -30.55 | -36.62 | -27.47 | -31.25 | Upgrade
|
| Change in Accounts Payable | -69.59 | 131.79 | -75.73 | 123.87 | 82.45 | Upgrade
|
| Change in Other Net Operating Assets | 35.37 | 81.68 | 16.37 | 1.2 | - | Upgrade
|
| Operating Cash Flow | 685.37 | 952.97 | 698.98 | 592.17 | 464.8 | Upgrade
|
| Operating Cash Flow Growth | -28.08% | 36.34% | 18.04% | 27.41% | 57.22% | Upgrade
|
| Capital Expenditures | -117.22 | -195.34 | -474.34 | -131.23 | -138.52 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.89 | 0.25 | 3.58 | 1.76 | 0.43 | Upgrade
|
| Cash Acquisitions | -1.2 | -8.13 | - | - | - | Upgrade
|
| Divestitures | - | 1.89 | 2.01 | - | - | Upgrade
|
| Investment in Securities | -91.42 | -447.98 | -101.07 | -103.07 | -251.23 | Upgrade
|
| Other Investing Activities | 38.7 | 32.04 | 25.94 | 61.44 | 25.97 | Upgrade
|
| Investing Cash Flow | -170.25 | -617.27 | -543.88 | -171.1 | -363.35 | Upgrade
|
| Short-Term Debt Issued | 5 | - | 3 | - | - | Upgrade
|
| Total Debt Issued | 5 | - | 3 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | -3.03 | - | -14 | - | Upgrade
|
| Long-Term Debt Repaid | -10.37 | -7.24 | -7.56 | -3.63 | -14 | Upgrade
|
| Total Debt Repaid | -10.37 | -10.27 | -7.56 | -17.63 | -14 | Upgrade
|
| Net Debt Issued (Repaid) | -5.37 | -10.27 | -4.56 | -17.63 | -14 | Upgrade
|
| Issuance of Common Stock | - | 18.81 | 167.35 | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | -40.06 | - | - | Upgrade
|
| Common Dividends Paid | -415.57 | -411.05 | -327.61 | -273.52 | -159.19 | Upgrade
|
| Other Financing Activities | -54.44 | 1.51 | 51.73 | 14.85 | 46.83 | Upgrade
|
| Financing Cash Flow | -475.38 | -400.99 | -153.15 | -276.3 | -126.35 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.08 | -0.11 | 0.06 | -0.01 | -0.07 | Upgrade
|
| Net Cash Flow | 39.82 | -65.4 | 2.01 | 144.76 | -24.97 | Upgrade
|
| Free Cash Flow | 568.15 | 757.64 | 224.64 | 460.94 | 326.27 | Upgrade
|
| Free Cash Flow Growth | -25.01% | 237.27% | -51.27% | 41.27% | 198.92% | Upgrade
|
| Free Cash Flow Margin | 22.40% | 26.44% | 9.64% | 21.25% | 19.18% | Upgrade
|
| Free Cash Flow Per Share | 0.34 | 0.45 | 0.14 | 0.29 | 0.20 | Upgrade
|
| Cash Income Tax Paid | 223.79 | 226.59 | 233.17 | 193.24 | 166.53 | Upgrade
|
| Levered Free Cash Flow | 365.07 | 591.82 | 194.46 | 450.42 | 259.16 | Upgrade
|
| Unlevered Free Cash Flow | 366.58 | 592.99 | 195.41 | 451.44 | 260.17 | Upgrade
|
| Change in Net Working Capital | 147.93 | -44.91 | -93.83 | -118.16 | -80.47 | Upgrade
|
Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.